Benefits of the bisphosphonates may extend beyond fracture prevention to include reductions in cardiovascular and cancer events and possibly mortality, according to a New Zealand trial. A more in-depth analysis of a six year trial of zoledronate in older women with osteopenia has found benefits on cardiovascular disease and some cancers consistent with those seen ...
Bisphosphonate benefits extend to cancer and cardiovascular events
By Michael Woodhead
30 Oct 2019